Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
Inventory
Heidelberg Pharma AG
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Heidelberg Pharma AG
XETRA:HPHA
|
Inventory
€11.8m
|
CAGR 3-Years
151%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Inventory
€110.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Inventory
€541k
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Inventory
€523.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Formycon AG
XETRA:FYB
|
Inventory
€262k
|
CAGR 3-Years
8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
Heidelberg Pharma AG
Glance View
Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The company is headquartered in Ladenburg, Baden-Wuerttemberg and currently employs 89 full-time employees. The company went IPO on 2006-11-13. The firm focuses on the research and development of therapy treatments for oncology area. The company aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC, prostate-specific membrane antigens, and CD19-ATAC, a B-lymphocyte antigen. Through partnerships, the Company develops clinical assets, including MESUPRON, REDECTANE and RENCAREX. The company also offers preclinical contract research services.
See Also
What is Heidelberg Pharma AG's Inventory?
Inventory
11.8m
EUR
Based on the financial report for Nov 30, 2024, Heidelberg Pharma AG's Inventory amounts to 11.8m EUR.
What is Heidelberg Pharma AG's Inventory growth rate?
Inventory CAGR 5Y
118%
Over the last year, the Inventory growth was 13%. The average annual Inventory growth rates for Heidelberg Pharma AG have been 151% over the past three years , 118% over the past five years .
